Atria (ATRAV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
22 Jul, 2026Executive summary
Net sales increased by 5.8% year-over-year to EUR 931.5 million in H1 2026, with EBIT up to EUR 34.6 million (3.7% of net sales).
All business areas reported improved EBIT, driven by strong retail and Foodservice sales, especially in Finland and Sweden.
Strategic investments continued in convenience food and production capacity across Finland and Sweden, including new production lines and packaging solutions.
Cost pressures from the Middle East conflict and geopolitical tensions began to impact results late in the period, with further impact expected.
A 25% stake in Cookin Food Sweden AB was acquired to strengthen the convenience food segment.
Financial highlights
H1 2026 net sales: EUR 931.5 million (+5.8% year-over-year); Q2 net sales: EUR 481.2 million (+4.6%).
H1 2026 EBIT: EUR 34.6 million (3.7% margin), up from EUR 30.5 million (3.5% margin) in H1 2025.
H1 2026 EPS: EUR 0.82 (up from EUR 0.69); Q2 EPS: EUR 0.47 (up from EUR 0.41).
Free cash flow for H1 2026 was EUR -14.6 million, down from EUR 44.0 million in H1 2025, mainly due to increased investments and working capital.
Dividend distributed: EUR 0.75 per share (vs. EUR 0.69 previous year).
Outlook and guidance
Adjusted EBIT for 2026 is expected to exceed the previous year’s EUR 69.9 million.
Positive EBIT development anticipated, supported by strong brands and customer relationships.
Risks include cost inflation from geopolitical tensions, unstable pork market, animal disease risks, and low consumer confidence.
Latest events from Atria
- Net sales up 7.1% and EBIT improved, driven by Nordic growth and strategic investments.ATRAV
Q1 202623 Apr 2026 - Profitable growth, convenience food expansion, and cross-border scaling drive strong results.ATRAV
CMD 202520 Mar 2026 - Record net sales and EBIT, major investments, and positive 2026 outlook despite market risks.ATRAV
Q4 202512 Feb 2026 - Q3 2025 saw broad-based sales and EBIT growth, major investments, and a raised EBIT outlook.ATRAV
Q3 202523 Oct 2025 - Net sales and EBIT rose, driven by Sweden and poultry efficiency, but 2025 outlook is cautious.ATRAV
Q2 202517 Jul 2025 - Adjusted EBIT up 30% year-over-year, driven by Sweden's growth and operational efficiency.ATRAV
Q3 202413 Jun 2025 - Profitability gains and operational improvements led to a raised EBIT outlook for 2024.ATRAV
Q2 202413 Jun 2025 - EBIT and net sales rose, but 2025 outlook is cautious amid geopolitical and labor risks.ATRAV
Q1 20255 Jun 2025 - Record adjusted EBIT and strong segment gains, but 2025 outlook cautious amid risks.ATRAV
Q4 20245 Jun 2025